NSD2 and neoplasm: We also depleted CD8+ T cells with anti–mouse CD8 mAbs in mice bearing WT or Whsc1-KO xenografts and found that neutralization of CD8+ T cells minimized the differences in tumor growth between mice bearing WT tumors and those with Whsc1-KO tumors (Figure 4K).